WallStreetZenWallStreetZen

NYSE: WST
West Pharmaceutical Services Inc Earnings & Revenue

WST past earnings growth

How has WST's earnings growth performed historically?
Company
3.51%
Industry
33.37%
Market
127.59%
WST's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
WST's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
WST's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

WST past revenue growth

How has WST's revenue growth performed historically?
Company
1.56%
Industry
8.14%
Market
19.39%
WST's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
WST's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
WST's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

WST earnings and revenue history

Current Revenue
$2.9B
Current Earnings
$568.7M
Current Profit Margin
19.4%
WST's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

WST Return on Equity

Current Company
20.4%
Current Industry
11.3%
Current Market
28.2%
WST's Return on Equity (20.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when WST announces earnings.

WST Return on Assets

Current Company
15.3%
Current Industry
7.6%
WST is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

WST Return on Capital Employed

Current Company
23.43%
Current Industry
10%
WST has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

WST vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
WST$2.93B$833.50M$568.70M+10.91%+20.98%
HOLX$3.96B$993.40M$466.50M+3.80%+3.62%
COO$3.73B$1.01B$339.90M+7.54%-4.57%
BAX$14.89B$4.36B$2.65B+6.10%+12.83%
RMD$4.58B$1.46B$958.38M+12.67%+15.88%

WST earnings dates

Next earnings date
Jul 25, 2024

West Pharmaceutical Services Earnings & Revenue FAQ

What were WST's earnings last quarter?

On Invalid Date, West Pharmaceutical Services (NYSE: WST) reported Q1 2024 earnings per share (EPS) of $1.57, up 16.49% year over year. Total West Pharmaceutical Services earnings for the quarter were $115.30 million. In the same quarter last year, West Pharmaceutical Services's earnings per share (EPS) was $1.88.

If you're new to stock investing, here's how to buy West Pharmaceutical Services stock.

What was WST's earnings growth in the past year?

As of Q3 2024, West Pharmaceutical Services's earnings has grown 3.51% year over year. This is 29.86 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 33.37%. West Pharmaceutical Services's earnings in the past year totalled $568.70 million.

What is WST's earnings date?

West Pharmaceutical Services's earnings date is Invalid Date. Add WST to your watchlist to be reminded of WST's next earnings announcement.

What was WST's revenue last quarter?

On Invalid Date, West Pharmaceutical Services (NYSE: WST) reported Q1 2024 revenue of $695.40 million up 2.96% year over year. In the same quarter last year, West Pharmaceutical Services's revenue was $716.60 million.

What was WST's revenue growth in the past year?

As of Q3 2024, West Pharmaceutical Services's revenue has grown 1.56% year over year. This is 6.58 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 8.14%. West Pharmaceutical Services's revenue in the past year totalled $2.93 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.